Organizers of the 2021 World Kidney Day (WKD) on March 11, which had as its theme “Living Well with Kidney Disease,” describe the important role of “family members and other care partners”in helping patients with kidney disease. But what is the difference between a caregiver and a care-partner? A caregiver provides care for someone who…
The World Kidney Day Steering Committee has declared 2021 the year of “Living Well with Kidney Disease”.
Strong motivation often provides the push to translate investigational technologies into real-world clinical use. Case in point: messenger RNA vaccines.
With the advent of more reliable and accurate ways to screen for prostate cancer, such as PSA testing and prostate MRI, the authors argue that it is time to stop the “antiquated practice” of the digital rectal examination.
Dialysis is not likely to become obsolete despite advances — and nephrology goes way beyond renal replacement therapy.
The practice of medicine is to the life sciences what finance and economics are to the mathematical disciplines. Both are wedged between STEM subjects and the humanities requiring skills emanating from both the right and left brain. Read any student’s application to medical school or residency program as they explain why medicine’s intersection of science…
Gradual transition to dialysis and palliative dialysis should be alternatives offered to patients with advanced chronic kidney disease, according to an editorial.
The rapid spread of coronavirus disease 2019 (COVID- 19) caught the world by surprise. Whatever becomes the new normal, the United States will be a different country from what it was on March 13, when President Donald J. Trump declared a national emergency. At this writing on May 28, more than 100,000 people in the…
I recently had reason to survey the progress made in renal cell cancer (RCC) over the last 70 or more years. In 1950, a patient who presented with metastatic RCC had a 0%-5% overall response rate (ORR) to the therapies of the time, with an anticipated overall survival (OS) of approximately 10 months. By 2005,…
During a session at the 2019 Genitourinary Cancers Symposium (GUCS) held recently in San Francisco, researchers presented findings from phase 3 studies showing that immunotherapy-based combination regimens are superior to sunitinib alone at improving progression-free survival among patients with previously untreated advanced kidney cancer. One study demonstrated improved overall survival. The study presenters concluded that…
